NMDAR Hypofunction Animal Models of Schizophrenia

被引：91
|
作者：
Lee, Gloria [1 ]
Zhou, Yi [1 ]
机构：
[1] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA
来源：
FRONTIERS IN MOLECULAR NEUROSCIENCE | 2019年 / 12卷
关键词：
NMDAR; NMDAR hypofunction; NMDAR antagonists; knockout mice; schizophrenia; animal models; 14-3-3; proteins; MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; AUDITORY-EVOKED POTENTIALS; INDUCED COGNITIVE DEFICITS; TARGETED POINT MUTATIONS; SUBUNIT GENE GRIN2B; MICE LACKING; PREPULSE INHIBITION; 14-3-3; PROTEINS;
D O I：
10.3389/fnmol.2019.00185
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The N-methyl-d-aspartate receptor (NMDAR) hypofunction hypothesis has been proposed to help understand the etiology and pathophysiology of schizophrenia. This hypothesis was based on early observations that NMDAR antagonists could induce a full range of symptoms of schizophrenia in normal human subjects. Accumulating evidence in humans and animal studies points to NMDAR hypofunctionality as a convergence point for various symptoms of schizophrenia. Here we review animal models of NMDAR hypofunction generated by pharmacological and genetic approaches, and how they relate to the pathophysiology of schizophrenia. In addition, we discuss the limitations of animal models of NMDAR hypofunction and their potential utility for therapeutic applications.
引用
收藏
页数：26
相关论文
共 50 条
  • [31] Subunit-specific NMDAR antagonism dissociates schizophrenia subtype-relevant oscillopathies associated with frontal hypofunction and hippocampal hyperfunction
    Benjamin Pittman-Polletta
    Kun Hu
    Bernat Kocsis
    Scientific Reports, 8
  • [32] Animal models of ERP dysfunction in schizophrenia
    Javitt, DC
    Schroeder, CE
    Specht, CM
    Lindsley, R
    Jayachandra, M
    PSYCHOPHYSIOLOGY, 1999, 36 : S14 - S14
  • [33] Promise and Pitfalls of Animal Models of Schizophrenia
    Feifel, David
    Shilling, Paul D.
    CURRENT PSYCHIATRY REPORTS, 2010, 12 (04) : 327 - 334
  • [34] Effects of(-)stepholidine in animal models for schizophrenia
    Bart A ELLENBROEK
    ActaPharmacologicaSinica, 2006, (09) : 1111 - 1118
  • [35] Effects of (-)stepholidine in animal models for schizophrenia
    Ellenbroek, Bart A.
    Zhang, Xue-xiang
    Jin, Guo-zhang
    ACTA PHARMACOLOGICA SINICA, 2006, 27 (09) : 1111 - 1118
  • [36] NEURODEVELOPMENTAL ANIMAL-MODELS OF SCHIZOPHRENIA
    LILLRANK, SM
    LIPSKA, BK
    WEINBERGER, DR
    CLINICAL NEUROSCIENCE, 1995, 3 (02) : 98 - 104
  • [37] CaMKIIα expression in a mouse model of NMDAR hypofunction schizophrenia: Putative roles for IGF-1R and TLR4
    Ogundele, O. M.
    Lee, C. C.
    BRAIN RESEARCH BULLETIN, 2018, 137 : 53 - 70
  • [38] An Overview of Animal Models Related to Schizophrenia
    Winship, Ian R.
    Dursun, Serdar M.
    Baker, Glen B.
    Balista, Priscila A.
    Kandratavicius, Ludmyla
    Maia-de-Oliveira, Joao Paulo
    Hallak, Jaime
    Howland, John G.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2019, 64 (01): : 5 - 17
  • [39] Genetic animal models: focus on schizophrenia
    Gainetdinov, RR
    Mohn, AR
    Caron, MG
    TRENDS IN NEUROSCIENCES, 2001, 24 (09) : 527 - 533
  • [40] Promise and Pitfalls of Animal Models of Schizophrenia
    David Feifel
    Paul D. Shilling
    Current Psychiatry Reports, 2010, 12 : 327 - 334
12345